Phaos Technology Holdings (Caym (POAS) stock declined over -1.58%, trading at $3.12 on AMEX, down from the previous close of $3.17. The stock opened at $3.07, fluctuating between $2.99 and $3.27 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jan 21, 2026 | 3.07 | 3.27 | 2.99 | 3.12 | 371.18K |
| Jan 20, 2026 | 3.08 | 3.32 | 3.07 | 3.17 | 124.39K |
| Jan 16, 2026 | 3.10 | 3.27 | 3.10 | 3.14 | 135.7K |
| Jan 15, 2026 | 3.25 | 3.26 | 3.07 | 3.10 | 155.42K |
| Jan 14, 2026 | 3.56 | 3.57 | 3.19 | 3.24 | 94.82K |
| Jan 13, 2026 | 3.62 | 3.79 | 3.50 | 3.64 | 4.7M |
| Jan 12, 2026 | 3.45 | 3.62 | 3.45 | 3.60 | 221.74K |
| Jan 09, 2026 | 3.50 | 3.64 | 3.40 | 3.55 | 477.56K |
| Jan 08, 2026 | 3.38 | 3.69 | 3.30 | 3.45 | 5.66M |
| Jan 07, 2026 | 3.38 | 3.49 | 3.29 | 3.42 | 937.15K |
| Jan 06, 2026 | 3.55 | 3.67 | 3.26 | 3.42 | 886.42K |
| Jan 05, 2026 | 3.15 | 3.46 | 3.15 | 3.35 | 88.24K |
| Jan 02, 2026 | 3.51 | 3.51 | 2.97 | 3.16 | 241.63K |
| Dec 31, 2025 | 3.62 | 3.73 | 3.43 | 3.43 | 158.18K |
| Dec 30, 2025 | 3.76 | 3.92 | 3.60 | 3.61 | 377.09K |
| Dec 29, 2025 | 3.75 | 3.94 | 3.75 | 3.76 | 1.4M |
| Dec 26, 2025 | 3.79 | 3.83 | 3.70 | 3.80 | 164.07K |
| Dec 24, 2025 | 3.75 | 3.85 | 3.74 | 3.75 | 214.27K |
| Dec 23, 2025 | 3.82 | 3.94 | 3.65 | 3.65 | 2.14M |
| Dec 22, 2025 | 3.75 | 3.81 | 3.75 | 3.80 | 304.01K |
Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software. The company serves manufacturing companies; biomedical service providers; and research and development institutions. The company was founded in 2017 and is based in Singapore.
| Employees | 25 |
| Beta | 0 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Medical - Devices |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep